Esophageal Cancer Clinical Trial

Predicting Disease Progression and/or Recurrence in Cancer

Summary

This is a prospective study addressing the challenge of predicting disease progression and/or recurrence in patients diagnosed with metastatic colorectal, pancreatobiliary, or esophagogastric cancer that are receiving anti-cancer therapy.

View Full Description

Full Description

This research study is evaluating how patient-reported outcomes (e.g. symptoms, quality of life) and biomarkers compare to standard of care clinical assessments such as imaging and tumor markers in predicting the clinical outcomes (e.g. disease progression and survival) in patient populations with colorectal, pancreatobiliary, or esophagogastric cancer that are receiving anti-cancer therapy Massachusetts General Hospital Cancer Center

Patient reported outcomes will be collected through a series of self-administered questionnaires and blood draws will be used to obtain bio and tumor marker information.
Information will also be collected from the participants electronic medical record.
Tissue may be obtained for next-generation sequencing.
The study will conclude after participants are no longer receiving anti-cancer therapies.
It is expected that about 200 people will take part in this research study

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients must have histologically confirmed colorectal, pancreatobiliary, or esophagogastric cancer.
Diagnosed with metastatic disease
Age > 18 years.
Patients must be starting new line of anti-cancer therapy.
Patient must be English-speaking.
Exclusion Criteria
Unwilling or unable to participate in the study
Non-metastatic disease
Not starting new anti-cancer treatment
Cognitive issues interfering with ability to participate.
Active, unstable, untreated serious mental illness interfering with ability to participate.
Patient does not speak English.

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

200

Study ID:

NCT04776837

Recruitment Status:

Completed

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

200

Study ID:

NCT04776837

Recruitment Status:

Completed

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider